Image of a stock market

Founders’ million-share selloff makes Pro Medicus one to watch

The two founders of Pro Medicus Ltd have sold 1 million shares each in the current…
3D image of the lungs

4D Medical inks deal with WA radiology clinics for ventilation report tech

Melbourne-based 4D Medical Ltd has signed a commercial contract with Perth Radiological Clinic to roll out…
Image of the human circulatory system

4DMedical secures $1.9M grant to ramp-up trials for ‘safer, cheaper’ lung imaging

The Federal government has awarded 4DMedical Ltd a grant worth $1.9M to fund its clinical trials…
Medical project manager using a laptop

Pro Medicus snaffles 5-year contract extension worth $32M for RIS technology

Healthcare informatics company Pro Medicus Ltd (ASX:PME) has signed a 5-year contract extension – valued at a minimum of $32 million –
Red broken heart with a band-aid on a wooden background

Echo IQ tests show heart failure can be detected in 86% of cases with AI

Echo IQ Ltd has successfully completed two clinical tests showing the viability of applying AI to…
3D image of pancreatic cancer

Oncosil device successfully treats pancreatic cancer in Türkiye

Oncosil Medical Ltd reported the successful reduction in tumor size through the use of its flagship…
Saccharomyces cerevisiae yeast, 3D illustration.

Tissue Repairs soars nearly 32% on TGA approval for wound healing gel

Biotech company Tissue Repair Ltd (ASX:TRP) has seen its share price rise more than 30% on news it had gained TGA (Therapeutic
advanced mri or ct scan medical diagnosis machine at hospital lab

Imricor raises $35M to pursue growth and expansion into Australia and NZ

Imricor Medical Systems Ltd intends to use the capital raising's funds to support a three-pronged growth…

Pacific Edge sees steady Cxbladder test results despite headwinds

Pacific Edge has posted steady growth in tests for its Cxbladder product, despite some corporate headwinds…
The Market Online Video

Recce reaches testing milestone for UTI, Uroseptis antibiotic

Recce Pharmaceuticals Limited (ASX: RCE) has completed tests involving a four-person cohort for its RECCE 327…